Honolulu, HI (June 13, 2017) – Aloha Green Holdings Inc. (Aloha Green) received its Notice to Proceed to Acquire and Cultivate Marijuana from the Hawaii State Department of Health (DOH) for Aloha Green’s second production center on Oahu – a purpose-built cannabis greenhouse the company has been developing with engineers and architects since the application. This is the first structure of its kind in the State of Hawaii for cannabis cultivation, allowing for a 400% increase in current production capability.
Aloha Green is currently leading the industry as the only licensee on Oahu to receive notice from the DOH for both production centers, in accordance with statutory and regulatory requirements. Aloha Green was the first Oahu licensee to receive a Notice to Proceed to begin cultivation in Production Center #1 on February 1, 2017. Production Center #1 is a computer controlled, environmentally sealed indoor cultivation nursery with advanced cannabis cultivation equipment. The Aloha Green also has opened the first and only dispensary in the state, though there are no cannabis products currently available for sale.
Aloha Green is now authorized to expand cultivation into Production Center #2, which was designed specifically to provide a stable environment for cannabis cultivation while taking advantage of the natural growing conditions in Hawaii and reducing carbon emissions. The greenhouse’s state-of-the-art opaque roof materials provide for superior natural sunlight diffusion for optimal plant health. It has computer controlled environmental systems, light deprivation, supplemental lighting, fan controls, heating, and cooling.
“By bringing our state-of-the-art greenhouse online, Aloha Green is able to meet current and future patient demand for safe lab-tested cannabis medicine,” states Tai Cheng, Chief Operating Officer of Aloha Green, “Aloha Green hopes to become a world leader in sustainably grown greenhouse cannabis.”
James H.Q. Lee, Chief Executive Officer, adds, “Aloha Green’s goal is to provide value-priced medicine to qualified patients. Greenhouse grown cannabis will use significantly less electricity than indoor grown cannabis. These savings are being passed on to the patients. The cost of living is already high in Hawaii, and the cost of medicine should not force patients to make the hard choice of whether to seek relief from their symptoms.”
Aloha Green is currently leading the industry as the only licensee on Oahu to receive notice from the DOH for both production centers, in accordance with statutory and regulatory requirements. Aloha Green was the first Oahu licensee to receive a Notice to Proceed to begin cultivation in Production Center #1 on February 1, 2017. Production Center #1 is a computer controlled, environmentally sealed indoor cultivation nursery with advanced cannabis cultivation equipment. The Aloha Green also has opened the first and only dispensary in the state, though there are no cannabis products currently available for sale.
Aloha Green is now authorized to expand cultivation into Production Center #2, which was designed specifically to provide a stable environment for cannabis cultivation while taking advantage of the natural growing conditions in Hawaii and reducing carbon emissions. The greenhouse’s state-of-the-art opaque roof materials provide for superior natural sunlight diffusion for optimal plant health. It has computer controlled environmental systems, light deprivation, supplemental lighting, fan controls, heating, and cooling.
“By bringing our state-of-the-art greenhouse online, Aloha Green is able to meet current and future patient demand for safe lab-tested cannabis medicine,” states Tai Cheng, Chief Operating Officer of Aloha Green, “Aloha Green hopes to become a world leader in sustainably grown greenhouse cannabis.”
James H.Q. Lee, Chief Executive Officer, adds, “Aloha Green’s goal is to provide value-priced medicine to qualified patients. Greenhouse grown cannabis will use significantly less electricity than indoor grown cannabis. These savings are being passed on to the patients. The cost of living is already high in Hawaii, and the cost of medicine should not force patients to make the hard choice of whether to seek relief from their symptoms.”
